aluates Reports

$ 0.0

Automative

Global Multiple Myeloma Therapy Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-27T14127

Global Multiple Myeloma Therapy Market Research Report 2023

BUY CHAPTERS

Global Multiple Myeloma Therapy Market Research Report 2025

Code: QYRE-Auto-27T14127

Report

July 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Celgene

Johnson & Johnson

GlaxoSmithKline PLC

AbbVie

Amgen Inc

Novartis

Millennium Pharmaceuticals

Innate Pharma SA

Roche

Multiple Myeloma Therapy Market Size

The global market for Multiple Myeloma Therapy was valued at US$ 24290 million in the year 2024 and is projected to reach a revised size of US$ 37030 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Multiple Myeloma Therapy Market

Multiple myeloma or plasma cell myeloma is a form of cancer of the plasma cells. In this condition, the body produces abnormal plasma cells which collect near the bone marrow and hamper normal functioning of the healthy plasma cells.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Multiple Myeloma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Myeloma Therapy.

The Multiple Myeloma Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiple Myeloma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Multiple Myeloma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Multiple Myeloma Therapy Market Report

Report Metric	Details
Report Name	Multiple Myeloma Therapy Market
Accounted market size in year	US$ 24290 million
Forecasted market size in 2031	US$ 37030 million
CAGR	6.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Targeted Therapy Chemotherapy Radiotherapy Bone Marrow Transplant Others
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Celgene, Johnson & Johnson, GlaxoSmithKline plc, Roche, AbbVie Inc., Amgen Inc., Novartis AG, Millennium Pharmaceuticals, Innate Pharma SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiple Myeloma Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Multiple Myeloma Therapy Market growing?

Ans: The Multiple Myeloma Therapy Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Multiple Myeloma Therapy Market size in 2031?

Ans: The Multiple Myeloma Therapy Market size in 2031 will be US$ 37030 million.

Who are the main players in the Multiple Myeloma Therapy Market report?

Ans: The main players in the Multiple Myeloma Therapy Market are Sanofi, Celgene, Johnson & Johnson, GlaxoSmithKline plc, Roche, AbbVie Inc., Amgen Inc., Novartis AG, Millennium Pharmaceuticals, Innate Pharma SA

What are the Application segmentation covered in the Multiple Myeloma Therapy Market report?

Ans: The Applications covered in the Multiple Myeloma Therapy Market report are Hospital, Clinic

What are the Type segmentation covered in the Multiple Myeloma Therapy Market report?

Ans: The Types covered in the Multiple Myeloma Therapy Market report are Targeted Therapy, Chemotherapy, Radiotherapy, Bone Marrow Transplant, Others

Recommended Reports

Cancer Therapy Markets

Hematology & Plasma Drugs

Cancer Biotherapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Multiple Myeloma Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Targeted Therapy

1.2.3 Chemotherapy

1.2.4 Radiotherapy

1.2.5 Bone Marrow Transplant

1.2.6 Others

1.3 Market by Application

1.3.1 Global Multiple Myeloma Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Multiple Myeloma Therapy Market Perspective (2020-2031)

2.2 Global Multiple Myeloma Therapy Growth Trends by Region

2.2.1 Global Multiple Myeloma Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Multiple Myeloma Therapy Historic Market Size by Region (2020-2025)

2.2.3 Multiple Myeloma Therapy Forecasted Market Size by Region (2026-2031)

2.3 Multiple Myeloma Therapy Market Dynamics

2.3.1 Multiple Myeloma Therapy Industry Trends

2.3.2 Multiple Myeloma Therapy Market Drivers

2.3.3 Multiple Myeloma Therapy Market Challenges

2.3.4 Multiple Myeloma Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Multiple Myeloma Therapy Players by Revenue

3.1.1 Global Top Multiple Myeloma Therapy Players by Revenue (2020-2025)

3.1.2 Global Multiple Myeloma Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Multiple Myeloma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Multiple Myeloma Therapy Revenue

3.4 Global Multiple Myeloma Therapy Market Concentration Ratio

3.4.1 Global Multiple Myeloma Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapy Revenue in 2024

3.5 Global Key Players of Multiple Myeloma Therapy Head office and Area Served

3.6 Global Key Players of Multiple Myeloma Therapy, Product and Application

3.7 Global Key Players of Multiple Myeloma Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Myeloma Therapy Breakdown Data by Type

4.1 Global Multiple Myeloma Therapy Historic Market Size by Type (2020-2025)

4.2 Global Multiple Myeloma Therapy Forecasted Market Size by Type (2026-2031)

5 Multiple Myeloma Therapy Breakdown Data by Application

5.1 Global Multiple Myeloma Therapy Historic Market Size by Application (2020-2025)

5.2 Global Multiple Myeloma Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Multiple Myeloma Therapy Market Size (2020-2031)

6.2 North America Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Multiple Myeloma Therapy Market Size by Country (2020-2025)

6.4 North America Multiple Myeloma Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Multiple Myeloma Therapy Market Size (2020-2031)

7.2 Europe Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Multiple Myeloma Therapy Market Size by Country (2020-2025)

7.4 Europe Multiple Myeloma Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Multiple Myeloma Therapy Market Size (2020-2031)

8.2 Asia-Pacific Multiple Myeloma Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Multiple Myeloma Therapy Market Size (2020-2031)

9.2 Latin America Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Multiple Myeloma Therapy Market Size by Country (2020-2025)

9.4 Latin America Multiple Myeloma Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Multiple Myeloma Therapy Market Size (2020-2031)

10.2 Middle East & Africa Multiple Myeloma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Multiple Myeloma Therapy Introduction

11.1.4 Sanofi Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Celgene

11.2.1 Celgene Company Details

11.2.2 Celgene Business Overview

11.2.3 Celgene Multiple Myeloma Therapy Introduction

11.2.4 Celgene Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.2.5 Celgene Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Multiple Myeloma Therapy Introduction

11.3.4 Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 GlaxoSmithKline plc

11.4.1 GlaxoSmithKline plc Company Details

11.4.2 GlaxoSmithKline plc Business Overview

11.4.3 GlaxoSmithKline plc Multiple Myeloma Therapy Introduction

11.4.4 GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.4.5 GlaxoSmithKline plc Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Multiple Myeloma Therapy Introduction

11.5.4 Roche Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.5.5 Roche Recent Development

11.6 AbbVie Inc.

11.6.1 AbbVie Inc. Company Details

11.6.2 AbbVie Inc. Business Overview

11.6.3 AbbVie Inc. Multiple Myeloma Therapy Introduction

11.6.4 AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.6.5 AbbVie Inc. Recent Development

11.7 Amgen Inc.

11.7.1 Amgen Inc. Company Details

11.7.2 Amgen Inc. Business Overview

11.7.3 Amgen Inc. Multiple Myeloma Therapy Introduction

11.7.4 Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.7.5 Amgen Inc. Recent Development

11.8 Novartis AG

11.8.1 Novartis AG Company Details

11.8.2 Novartis AG Business Overview

11.8.3 Novartis AG Multiple Myeloma Therapy Introduction

11.8.4 Novartis AG Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.8.5 Novartis AG Recent Development

11.9 Millennium Pharmaceuticals

11.9.1 Millennium Pharmaceuticals Company Details

11.9.2 Millennium Pharmaceuticals Business Overview

11.9.3 Millennium Pharmaceuticals Multiple Myeloma Therapy Introduction

11.9.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.9.5 Millennium Pharmaceuticals Recent Development

11.10 Innate Pharma SA

11.10.1 Innate Pharma SA Company Details

11.10.2 Innate Pharma SA Business Overview

11.10.3 Innate Pharma SA Multiple Myeloma Therapy Introduction

11.10.4 Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2020-2025)

11.10.5 Innate Pharma SA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Celgene

Johnson & Johnson

GlaxoSmithKline PLC

AbbVie

Amgen Inc

Novartis

Millennium Pharmaceuticals

Innate Pharma SA

Roche

List of Tables

Table 1. Global Multiple Myeloma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Targeted Therapy

Table 3. Key Players of Chemotherapy

Table 4. Key Players of Radiotherapy

Table 5. Key Players of Bone Marrow Transplant

Table 6. Key Players of Others

Table 7. Global Multiple Myeloma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Multiple Myeloma Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Multiple Myeloma Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Multiple Myeloma Therapy Market Share by Region (2020-2025)

Table 11. Global Multiple Myeloma Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Multiple Myeloma Therapy Market Share by Region (2026-2031)

Table 13. Multiple Myeloma Therapy Market Trends

Table 14. Multiple Myeloma Therapy Market Drivers

Table 15. Multiple Myeloma Therapy Market Challenges

Table 16. Multiple Myeloma Therapy Market Restraints

Table 17. Global Multiple Myeloma Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Multiple Myeloma Therapy Market Share by Players (2020-2025)

Table 19. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2024)

Table 20. Ranking of Global Top Multiple Myeloma Therapy Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Multiple Myeloma Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Multiple Myeloma Therapy, Headquarters and Area Served

Table 23. Global Key Players of Multiple Myeloma Therapy, Product and Application

Table 24. Global Key Players of Multiple Myeloma Therapy, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Multiple Myeloma Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Multiple Myeloma Therapy Revenue Market Share by Type (2020-2025)

Table 28. Global Multiple Myeloma Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Multiple Myeloma Therapy Revenue Market Share by Type (2026-2031)

Table 30. Global Multiple Myeloma Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Multiple Myeloma Therapy Revenue Market Share by Application (2020-2025)

Table 32. Global Multiple Myeloma Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Multiple Myeloma Therapy Revenue Market Share by Application (2026-2031)

Table 34. North America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Multiple Myeloma Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Multiple Myeloma Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Multiple Myeloma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Multiple Myeloma Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 49. Sanofi Company Details

Table 50. Sanofi Business Overview

Table 51. Sanofi Multiple Myeloma Therapy Product

Table 52. Sanofi Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 53. Sanofi Recent Development

Table 54. Celgene Company Details

Table 55. Celgene Business Overview

Table 56. Celgene Multiple Myeloma Therapy Product

Table 57. Celgene Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 58. Celgene Recent Development

Table 59. Johnson & Johnson Company Details

Table 60. Johnson & Johnson Business Overview

Table 61. Johnson & Johnson Multiple Myeloma Therapy Product

Table 62. Johnson & Johnson Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 63. Johnson & Johnson Recent Development

Table 64. GlaxoSmithKline plc Company Details

Table 65. GlaxoSmithKline plc Business Overview

Table 66. GlaxoSmithKline plc Multiple Myeloma Therapy Product

Table 67. GlaxoSmithKline plc Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 68. GlaxoSmithKline plc Recent Development

Table 69. Roche Company Details

Table 70. Roche Business Overview

Table 71. Roche Multiple Myeloma Therapy Product

Table 72. Roche Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 73. Roche Recent Development

Table 74. AbbVie Inc. Company Details

Table 75. AbbVie Inc. Business Overview

Table 76. AbbVie Inc. Multiple Myeloma Therapy Product

Table 77. AbbVie Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 78. AbbVie Inc. Recent Development

Table 79. Amgen Inc. Company Details

Table 80. Amgen Inc. Business Overview

Table 81. Amgen Inc. Multiple Myeloma Therapy Product

Table 82. Amgen Inc. Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 83. Amgen Inc. Recent Development

Table 84. Novartis AG Company Details

Table 85. Novartis AG Business Overview

Table 86. Novartis AG Multiple Myeloma Therapy Product

Table 87. Novartis AG Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 88. Novartis AG Recent Development

Table 89. Millennium Pharmaceuticals Company Details

Table 90. Millennium Pharmaceuticals Business Overview

Table 91. Millennium Pharmaceuticals Multiple Myeloma Therapy Product

Table 92. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 93. Millennium Pharmaceuticals Recent Development

Table 94. Innate Pharma SA Company Details

Table 95. Innate Pharma SA Business Overview

Table 96. Innate Pharma SA Multiple Myeloma Therapy Product

Table 97. Innate Pharma SA Revenue in Multiple Myeloma Therapy Business (2020-2025) & (US$ Million)

Table 98. Innate Pharma SA Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Multiple Myeloma Therapy Picture

Figure 2. Global Multiple Myeloma Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Multiple Myeloma Therapy Market Share by Type: 2024 VS 2031

Figure 4. Targeted Therapy Features

Figure 5. Chemotherapy Features

Figure 6. Radiotherapy Features

Figure 7. Bone Marrow Transplant Features

Figure 8. Others Features

Figure 9. Global Multiple Myeloma Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Multiple Myeloma Therapy Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Multiple Myeloma Therapy Report Years Considered

Figure 14. Global Multiple Myeloma Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Multiple Myeloma Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Multiple Myeloma Therapy Market Share by Region: 2024 VS 2031

Figure 17. Global Multiple Myeloma Therapy Market Share by Players in 2024

Figure 18. Global Top Multiple Myeloma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapy Revenue in 2024

Figure 20. North America Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Multiple Myeloma Therapy Market Share by Country (2020-2031)

Figure 22. United States Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Multiple Myeloma Therapy Market Share by Country (2020-2031)

Figure 26. Germany Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Multiple Myeloma Therapy Market Share by Region (2020-2031)

Figure 34. China Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Multiple Myeloma Therapy Market Share by Country (2020-2031)

Figure 42. Mexico Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Multiple Myeloma Therapy Market Share by Country (2020-2031)

Figure 46. Turkey Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Multiple Myeloma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Sanofi Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 50. Celgene Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 51. Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 52. GlaxoSmithKline plc Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 53. Roche Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 54. AbbVie Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 55. Amgen Inc. Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 56. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 57. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 58. Innate Pharma SA Revenue Growth Rate in Multiple Myeloma Therapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Monoclonal Antibody for Multiple Myeloma Market Research Report 2024

Global Hematological Cancers Market Research Report 2024

Global Immunomodulator for Multiple Myeloma Market Research Report 2024

Global ImmunOthersapy Drugs for Multiple Myeloma Market Research Report 2024

Blood Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Myelofibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for Multiple Myeloma Market Research Report 2024

Lenalidomide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood and Bone Marrow Cancer Treatment Market Insights Forecast to 2030

Global Blood Cancer Treatments Market Research Report 2024

Global Traditional ChemOthersapy Drugs for Multiple Myeloma Market Research Report 2024

Hematologic Malignancies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lymphoma Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Multiple Myeloma Treatment Market Research Report 2024

Refractory Multiple Myeloma Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Cancer Therapeutics Market Insights Forecast to 2030

Global Melphalan Injection Market Research Report 2024

Global Targeted Therapy for Brain Cancer Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions